| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Lifestyle-related risk factors for stomach cancer in northeast Thailand. | Suwanrungruang, K Sriamporn, S Wiangnon, S Rangsrikajee, D Sookprasert, A Thipsuntornsak, N Satitvipawee, P Poomphakwaen, K Tokudome, S |
0 | ||||
| 2. | Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985-2004. | Suwanrungruang, K Wiangnon, S Sriamporn, S Sookprasert, A Rangsrikajee, D Kamsa-Ard, S Horsith, S Usantia, P |
0 | ||||
| 3. | Studies on ATP level in erythrocytes of patients with Plasmodium falciparum malaria. | Sookprasert, A. | 1975 | ||||
| 4. | Itraconazole in cryptococcal meningitis in pregnancy: A case report | Chotmongkol, V Sookprasert, A |
1992 | ||||
| 5. | Clinical Use of Erythropoietin | Aumkhae Sookprasert Kanchana Chansung Chitima Sirjerachai |
2000 | ||||
| 6. | Hypersensitivity to Intravenous Form of Etoposide and Successfully Rechallenged with Oral Form : a Case Report and Review of Literature | Aumkhae Sookprasert Jaruwun Chaiworamukul Teerasak Kaewamatavong Ploysyne Busaracome |
2000 | ||||
| 7. | Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma | O. Sea Sew A. Sookprasert V. Bhudhisawad V. Kaewket C. Pirojkul |
2004 | ||||
| 8. | Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985-2004 | Suwanrungruang, K. Wiangnon, S. Sriamporn, S. Sookprasert, A. Rangsrikajee, D. Kamsa-ard, S. Horsith, S. Usantia, P. |
2006 | ||||
| 9. | Exploration of pain management following implementation of WHO pain guidelines | S. Subongkot S. Khounnikhom N. Pratheepawanit Johns A. Sookprasert |
2007 | ||||
| 10. | Lifestyle-related risk factors for stomach cancer in Northeast Thailand | Suwanrungruang, K. Sriamporn, S. Wiangnon, S. Rangsrikajee, D. Sookprasert, A. Thipsuntornsak, N. Poomphakwaen, K. |
2008 | ||||
| 11. | Prevalence and management of cancer pain in Srinagarind Hospital, Khon Kaen, Thailand. | Vatanasapt, P. Lertsinudom, S. Sookprasert, A. Phunmanee, A. Pratheepawanit, N. Bpharm, S.W. Juangpanich, U. Treapkhuntong, T. |
2008 | ||||
| 12. | Randomized, single-blind, crossover trial comparing the antiemetic effect of tropisetron or generic ondasetron plus corticosteriods in patients receiving high dose cisplatin-containing chemotherapy | S. Subongkot Y. Payanta A. Sookprasert |
2008 | ||||
| 13. | RANDOMIZED, PLACEBO, CONTROLLED, DOUBLE-BLIND TRIAL OF MELATONIN IN CHOLANGIOCARCINOMA PATIENTS | W. Manprasert N. P. Johns A. Sookprasert J. Kantpittaya J. Johns J. Konsil T. Weerapreeyakul P. Phongthai S. Porasutpathana W. Laolukana |
2010 | ||||
| 14. | Brain metastases from cholangiocarcinoma: A first case series in thailand | Jarin Chindaprasirt Aumkhae Sookprasert Kittisak Sawanyawisuth Panita Limpawattana Somsak Tiamkao |
2012 | ||||
| 15. | Cancer in Pregnancy: 10- year Experience in Srinagarind Hospital | Kosin Wirasorn Jarin Chindaprasirt Aumkhae Sookprasert Chompilas Chongsomchai |
2012 | ||||
| 16. | Cost of colorectal cancer care in hospitalized patients of Thailand. | Chindaprasirt, P. Chindaprasirt, J. Sookprasert, A. Wirasorn, K. Limpawattana, P. Sutra, S. Thavornpitak, Y. |
2012 | ||||
| 17. | Evaluation of efficacy, safety and tolerability of high dose-intermittent calcitriol supplementation to advanced intrahepatic cholangiocarcinoma patients--a pilot study. | Sookprasert, A. Pugkhem, A. Khuntikeo, N. Chur-In, S. Chamadol, N. Prawan, A. Janeklang, S. Vaeteewoottacharn, K. Kukongviriyapan, V. Pairojkul, C. Bhudhisawasdi, V. Wongkham, S. |
2012 | ||||
| 18. | Lung cancer in hospitalized patients of Thailand. | Phunmanee, A. Wirasorn, K. Thavornpitak, Y. Sookprasert, A. Chindaprasirt, J. Chindaprasirt, P. |
2012 | ||||
| 19. | Patterns of chemotherapy usage in hospitalized breast cancer patients. | Sookprasert, A Chindaprasirt, J Wirasorn, K Limpawattana, P Thavornpitak, Y |
2012 | ||||
| 20. | Systemic therapy for locally advanced and metastatic cholangiocarcinoma | Sookprasert, A Chindaprasert, J Wirasorn, K |
2012 | ||||
| 21. | Adjuvant chemotherapy in patients with resectable cholangiocarcinoma | Kosin Wirasorn Thundon Ngamprasertchai Narong Khantikaew Ake Pakkhem Piti Ungarereevittaya Jarin Jindaprasert Aumkhae Sookprasert |
2013 | ||||
| 22. | Adjuvant chemotherapy in resectable cholangiocarcinoma patients | Wirasorn, K. Ngamprasertchai, T. Khuntikeo, N. Pakkhem, A. Ungarereevittaya, P. Chindaprasirt, P. Chindaprasirt, J. Sookprasert, A. |
2013 | ||||
| 23. | CAREGIVER BURDEN OF OLDER ADULTS WITH CANCER: A CROSS-SECTIONAL STUDY | J. Chindaprasirt P. Limpawattana P. Pakkaratho K. Wirasorn A. Sookprasert |
2013 | ||||
| 24. | Effectiveness of aromatherapy with light thai massage for cellular immunity improvement in colorectal cancer patients receiving chemotherapy. | Promthet, S.S. Sukprasert, A. Eunhpinitpong, W. Bradshaw, P. |
2013 | ||||
| 25. | Group versus modified individual standard-setting on multiple-choice questions with the Angoff method for fourth-year medical students in the internal medicine clerkship. | Senthong, V Chindaprasirt, J Sawanyawisuth, K Aekphachaisawat, N Chaowattanapanit, S Limpawattana, P Choonhakarn, C Sookprasert, A |
2013 | ||||
| 26. | MORTALITY, LENGTH OF STAY, AND COST ASSOCIATED WITH HOSPITALISED ADULT CANCER PATIENTS WITH FEBRILE NEUTROPENIA | J. Chindaprasirt C. Wanitpongpun P. Limpawattana K. Thepsuthammarat W. Sripakdee A. Sookprasert |
2013 | ||||
| 27. | Mortality, length of stay, and cost associated with hospitalized adult cancer patients with febrile neutropenia. | Jarin Chindaprasirt Chinadol Wanitpongpun Panita Limpawattana Kaewjai Thepsuthammarat Warunsuda Sripakdee Kosin Wirasorn Aumkhae Sookprasert |
2013 | ||||
| 28. | Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. | Kosin Wirasorn Thundon Ngamprasertchai Jarin Chindaprasirt Aumkhae Sookprasert Narong Khantikaew Ake Pakkhem Piti Ungarereevittaya |
2013 | ||||
| 29. | The application of telephone call back to survey the incidences of adverse drug events of ambulatory oncology patients | Sirikarn Kawin-atichart Preeyanuch Weeraprasit Nantanat Prempraphan Khon Kaen University Pharmaceutical sciences Aumkhae Sookprasert 40002 Khon Kaen Suthan Chanthawong Khon Kaen University Faculty of Pharmaceutical sciences |
2013 | ||||
| 30. | A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy. | Jitprapa Konmun Kwanjit Danwilai Nuttapong Ngamphaiboon Aumkhae Sookprasert Ekaphop Sirachainan Suphat Subongkot |
2014 | ||||
| 31. | Burdens among caregivers of older adults with advanced cancer and risk factors | Jarin Chindaprasirt Panita Limpawattana Pornvaree Pakkaratho Kosin Wirasorn Aumkhae Sookprasert Kannikar Kongbunkiat Kittisak Sawanyawisuth |
2014 | ||||
| 32. | Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. | Chanthawong, S. Subongkot, S. Sookprasert, A. |
2014 | ||||
| 33. | Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial. | Sookprasert, A. Johns, N.P. Pnunmanee, A. Pongthai, P. Cheawchanwattana, A. Johns, J.R. Konsil, J. Plaimee, P. Porasuphatana, S. Jitpimolmard, S. |
2014 | ||||
| 34. | Economic Evaluation of Melatonin as Adjuvant Lung Cancer Treatment : A Comparision of Melatonin with Chemotherapy and Chemotherapy Alone | Thanida Inthawong Nusaraporn Kessomboon Aumkhae Sookprasert Anakapong Phunmanee Parichart Pongthai Areewan Cheawchanwattana Nutjaree Pratheepawanit Johns |
2015 | ||||
| 35. | Excision repair cross-complementation group 1 (ERCC1) protein expression and clinical outcome in resectable cholangiocarcinoma | Kosin Wirasorn Mongkhon Sompornrattanaphan Sakkarn Sangkhamannon Sakda Waraasawapati Aumkhae Sookprasert Narong Khuntikao Ake Pakkhem |
2015 | ||||
| 36. | High-Grade Glioma: Treatment and Molecular Markers | Jarin Chindaprasirt Kosin Wirasorn Aumkhae Sookprasert |
2015 | ||||
| 37. | Hospital-based population of elderly cancer cases in Northeastern Thailand | Wirasorn, K Suwanrungruang, K Sookprasert, A Limpawattana, P Sirithanaphol, W Chindaprasirt, J |
2016 | ||||
| 38. | The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy | Duanggamon Muengsaen Suda Vannaprasaht Wichittra Tassaneeyakul Kritiya Butthongkomvong Thipawan Bowornkitiwong Luangyot Thongthieang Parichart Pongthai Kosin Wirasorn Aumkhae Sookprasert |
2016 | ||||
| 39. | Treatment outcome and predictors of survival in Thai adult rhabdomyosarcoma cases | Sookprasert, A Ungareewittaya, P Manotepitipongse, A Wirasorn, K Chindaprasirt, J |
2016 | ||||
| 40. | A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. | Sookprasert, A. Subongkot, S. |
2017 | ||||
| 41. | Prognostic factors for large symptomatic gists: A pragmatic study of experiences from a University hospital over 10 years | Prasertcharoensuk, S Thanapongpornthana, P Bhudhisawasdi, V Pugkhem, A Jenwitheesuk, K Sookprasert, A Pairojkul, Ch |
2017 | ||||
| 42. | Programmed death-ligand 1 (PD-L1) expression associated with a high neutrophil/lymphocyte ratio in cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 | ||||
| 43. | Symptoms, Symptom Management and Outcome in Cancer Patients Undergoing Chemotherapy | Apinya Karomprat Phetpilin Chaichan Umaporn Santawesuk Aumkhae Sookprasert |
2017 | ||||
| 44. | Translation and validation of the Thai version of Family Reported Outcome Measure (Thai FROM-16VC) in Thai family members of cancer patients | S. Subongkot P. Chantarasap N. P. Johns S. Pairojkul A. Sookprasert |
2017 | ||||
| 45. | Breast Cancer Incidence Trends and Projections in Northeastern Thailand. | Chindaprasirt, J. Wirasorn, K. Sookprasert, A. Somintara, O. Vachirodom, D. Koonmee, S. Srinakarin, J. Kamsa-Ard, S. Suwanrungruang, K. Sriplung, H. Wiangnon, S. |
2018 | ||||
| 46. | Monitoring methotrexate level in adult patients with osteosarcoma: A proposed algorithm for Thai patients | Patanasethanont, D. Wirasorn, K. Sookprasert, A. Chindaprasirt, J. |
2018 | ||||
| 47. | Outcome and prognostic factors of brain metastasis from solid organ tumor: A 10-year follow-up | Chindaprasirt, J. Sookprasert, A. |
2018 | ||||
| 48. | Outcomes of multidisciplinary treatment in penile cancer: Experience from Thailand. | Wichien Sirithanaphol Kachit Pachirat Ukrit Rompsaithong Pakorn Kiatsopit Supanut Lumbiganon Aumkhae Sookprasert |
2018 | ||||
| 49. | Prognostic factors of hypercalcemia of malignancy | Sookprasert, A. Chindaprasirt, J. Wirasorn, K. |
2018 | ||||
| 50. | Superior vena cava syndrome: Clinical presentation and treatment outcome | Sookprasert, A. Chindaprasirt, J. Wirasorn, K. |
2018 | ||||
| 51. | The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients | Limpawattana, P Theerakulpisut, D Wirasorn, K Sookprasert, A Khuntikeo, N Chindaprasirt, J |
2018 | ||||
| 52. | Thrombotic microangiopathy associated with gemcitabine: A case report | Chindaprasirt, J. Sookprasert, A. Wirasorn, K. Kritmetapak , K Puapiroj, A. |
2018 | ||||
| 53. | Treatment outcomes of adult osteosarcoma in Srinagarind Hospital. | P. Eiamprapaporn A. Sookprasert K. Wirasorn P. Ungarereevittaya J. Chindaprasirt |
2018 | ||||
| 54. | A phase Ib/II open label study of IMU-131 HER2/Neu peptide vaccine plus cisplatin and either 5-fluorouracil or capecitabine chemotherapy in patients with HER2/Neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. | Ursula Wiedermann Anthony J. Good Erika Garner-Spitzer Yee Chao Iurie Bulat Arunee Dechaphunkul Wichit Arpornwirat Chaiyut Charoentum Chia-Jui Yen Thomas Cheung Yau Marina Maglakelidze Suebpong Tanasanvimon Jedzada Maneechavakajorn Aumkhae Sookprasert Li-Yuan Bai Wen-Chi Chou Teerapat Ungtrakul Leslie Chong Nick Ede |
2019 | ||||
| 55. | A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach | Ursula Wiedermann Erika Garner-Spitzer Yee Chao Iurie Bulat Arunee Dechaphunkul Wichit Arpornwirat Chaiyut Charoentum Chia-Jui Yen Thomas Cheung Yau Marina Maglakelidze Suebpong Tanasanvimon Jedzada Maneechavakajorn Aumkhae Sookprasert Li-Yuan Bai Wen-Chi Chou Teerapat Ungtrakul Christoph C. Zielinski Leslie Chong Nick Ede Anthony J. Good |
2019 | ||||
| 56. | Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced gastric cancer | U. Wiedermann E. Garner-Spitzer Y. Chao I. Bulat A. Dechaphunkul W. Arpornwirat C. Charoentum C. J. Yen T. Yau M. Maglakelidzde S. Tanasanvimon J. Maneechavakajorn A. Sookprasert L-Y. Bai W-C. Chou T. Ungtrakul C. C. Zielinski L. Chong N. Ede A. Good |
2019 | ||||
| 57. | Crizotinib-Associated Renal Cysts in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients: A Single-Center Experience | Eiamprapaporn, P Mungwatthana, N Twinprai, P Sookprasert, A Chindaprasirt, J Ahooja, A Watthanaudomrot, S Sirithanaphol, W |
2019 | ||||
| 58. | Frailty syndrome in biliary tract cancer patients: Prevalence and associated factors | Limpawattana, P Wirasorn, K Sookprasert, A Sawanyawisuth, K Titapun, A Luvira, V Khuntikeo, N Chindaprasirt, J |
2019 | ||||
| 59. | Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial | Barrios, C.H.E. Liu, X. Ativitavas, T. Sookprasert, A. |
2019 | ||||
| 60. | Safety, efficacy, and pharmacokinetic (PK) profile of cosibelimab, an anti-PD-L1 antibody, in patients (pts) with advanced cancers | P. R. Clingan A. M. Mant G. E. Richardson D. M. Kowalski P. Koralewski I. Lugowska A. Dechaphunkul C. Charoentum A. Sookprasert V. Sriuranpong A. Akopov V. Kozlov N. Fadeeva B. Kasparov N. V. Kovalenko V. Oschepkov L. Gorelik Y. Kunes J. Oliviero D. L. Harris |
2019 | ||||
| 61. | Validation of the Thai version of the family reported outcome measure (FROM-16)(c) to assess the impact of disease on the partner or family members of patients with cancer | Pattariya Chantarasap Nutjaree Pratheepawanit Johns Srivieng Pairojkul Aumkhae Sookprasert Kosin Wirasorn Areewan Cheawchanwattana Sam Salek Suphat Subongkot |
2019 | ||||
| 62. | Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer | Chantarasap, P Johns, NP Pairojkul, S Sookprasert, A Wirasorn, K Cheawchanwattana, A Salek, S Subongkot, S |
2019 | ||||
| 63. | Prevalence of Geriatric Syndromes in Elderly Cancer Patients Receiving Chemotherapy. | Limpawattana, P. Sookprasert, A. Sirithanaphol, W. |
2020 | ||||
| 64. | Prognostic Factors for Penile Cancer and Survival in Response to Multimodality Therapy | Sirithanaphol, W. Sookprasert, A. Wirasorn, K. Chindaprasirt, J. |
2020 | ||||
| Count | 35 | 32 | 30 | 8 | |||
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|